Biogen’s commitment to improving patients’ lives goes further than scientific research and development. We look beyond the patient’s condition and see the whole person.
Through ongoing dialogue and dedicated research, and through dialogue with advocacy groups, we work to support patients and work to address key concerns. These include drug availability and safety, access to drug information, expanded access programmes, accelerating clinical development and approval timelines, improving the success rates of treatment and improving the overall patient experience.
As a result of our patient engagement efforts, Biogen developed patient mentoring programmes; made significant investments in R&D, both within our own organisation and in collaboration with others; worked with regulators to consider options for accelerating drug approvals and expand access to treatment; and provided advocacy groups with both financial aid and capacity building.